Posted 7/22/2019 1:27 PM (GMT -7)
After a nearly five year run on Zytiga, then Xtandi, my PSA is rising. I learned about a phase one trial with a drug from Arvinas called ARV-110. My local onco and my MDA onco agreed that this is an opportune time to try this new drug. My PSA, around the 6 level was not sky high. So I was referred to the Sarah Cannon Center in Nashville, was screened and accepted. I am on day six of dosing. It is two tabs by mouth per day. No SE yet. I had to do a two week wash out meaning I stopped taking Xtandi. PSA jumped to 8. As I understand, instead of blocking androgen like Zytiga and Xtandi, this drug targets the receptors and degrades them. So here we go. Let's hope this works.